Acuitas said it collaborated with CureVac to develop vaccine technology CureVac accused of omitting Acuitas scientists from patent applications Nov 14 (Reuters) - Biotech company Acuitas Therapeutics ...
April 25 (Reuters) - Biotech company Acuitas Therapeutics and Germany-based CureVac (5CV.DE), opens new tab have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, ...
The MarketWatch News Department was not involved in the creation of this content. -- Key presentation unveiled Acuitas' Next-Generation LNP Advancements, which is designed to enhance potency and ...
FARGO, N.D. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results